Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales

Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth. Biopharmaceutical company Puma Biotechnology Inc. (PBYI:NADSAQ) shares opened more than 20% higher to...
Streetwise Reports | August 14, 2019 |

Energy Major's Domestic Revenue Likely Lower Q1/19; Will Turn Around in Q2/19

Raymond James detailed what it expects for two of the company's business segments, domestically and internationally, in these two quarters and beyond. In an April 1 research note, analyst Praveen Narra reported that Raymond James lowered its Q1/19 domestic estimates for...
Streetwise Reports | April 5, 2019 |

Bacteria Test Developer Reiterates Revenue Should Double in 2019

The product expected to drive that outcome is discussed in an H.C. Wainwright & Co. report. In a May 31 research note, analyst Ram Selvaraju reported that H.C. Wainwright & Co. lowered its target price on T2 BioSystems Inc. (TTOO:NASDAQ) to $10 per sha...
Streetwise Reports | June 10, 2019 |

Coverage Initiated on Energy Efficiency Firm, 'One of a Kind Stock'

The thesis for investing in this company is provided in a Raymond James report. In a Nov. 21 research note, analyst Pavel Molchanov reported that Raymond James initiated coverage on Ameresco Inc. (AMRC:NYSE) with a Strong Buy rating and a $20 per share target price....
Streetwise Reports | December 2, 2019 |

Here’s a Company That’s Behind the Wheel Driving E-Commerce Growth

Logiq Inc. ( NEO.LGIQ , OTCMKTS: LGIQ , Forum) an E-commerce company that’s quickly transforming how companies operate and compete for growth while boasting multi-faceted revenue sources. When Stockhouse last caught up with Logiq back in late August , ...
Dave Jackson | November 12, 2021 |

Several Data Catalysts Expected in 2019 for 'Underappreciated Story'

An H.C. Wainwright & Co. report discussed what those are and why they could impact the biotech's valuation. In a March 18 research note, H.C. Wainwright & Co. analyst Andrew Fein purported that Constellation Pharmaceuticals Inc.'s (CNST:NASDAQ) "strong and balanced pi...
Streetwise Reports | March 25, 2019 |

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming

A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report. In a May 13 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc.'s (VIVE:NASDAQ) Q1/19 "reads fine." Q1/19 rev...
Streetwise Reports | May 16, 2019 |

U.S. Energy Firm's Stock at 'Good Entry Point,' Rating Upgraded to Outperform

An update on this company's valuation is provided in a Raymond James report. In an Aug. 13 research note, analyst Pavel Molchanov reported that Raymond James boosted its rating on Chart Industries Inc. (GTLS:NASDAQ) to Outperform from Market Perform, "...
Streetwise Reports | August 20, 2019 |

Accuray Shares Rise on Q2 Earnings, Increased Backlog and Raised FY/20 EBITDA Guidance

Shares of Accuray traded 15% higher today after the company reported Q2/20 financial results. Late yesterday afternoon, radiation oncology company Accuray Inc. (ARAY:NASDAQ) , which develops, manufactures and markets radiotherapy systems used in cancer trea...
Streetwise Reports | January 30, 2020 |

Texas Oilfield Services Firm 'Well Positioned for 2020'

The factors contributing to the company's status and financial expectations for this year are discussed in a Raymond James report. In a Jan. 21 research note, Raymond James analyst Praveen Narra reported that Halliburton Co. (HAL:NYSE) is "well positioned ...
Streetwise Reports | January 30, 2020 |
1 2 3 4 5 6 7 8 9 10 ...